Cancer

Successful phase 3 trial of drug for liver cancer

An international phase 3 trial has found that the drug regorafenib improved survival in patients with advanced hepatocellular carcinoma (HCC), a form of liver cancer, giving people who previously had no other options a better ...

Jan 18, 2017
popularity15 comments 0

Skin cancer model boost for prevention and treatment

Researchers at the University of Dundee have found that skin cancers in mice can closely mirror those found in humans, offering a model that could be used to help develop new drugs and find new ways of preventing the disease.

23 hours ago
popularity2 comments 0